News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
- Othercambridgeindependent.co.uk, 24 Jul 2026First patient is dosed in Healx HLX-4310 trial backed by Sunshine Project consortium
- OtherGlobeNewswire, 22 Jul 2026Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
- OtherThe Clinical Trial Vanguard, 22 Jul 2026Healx Doses First Patient in HLX-4310 Trial for Metastatic Osteosarcoma
- OtherGlobeNewswire, 22 Jul 2026Healx Announces First Patient Dosed in Phase 1/2 Trial to
- OtherBusiness Weekly, 21 Jul 2026Healx reveals first patient dosing in fight against rare bone cancer
- ExpansionBusiness Wire, 21 May 2026CAN Community Health Launches Healx Solutions to Expand Access in Specialty Therapy Services
- OtherBusiness Weekly, 22 Sept 2025Healx AI alliance with US-based Vuja De Sciences targets killer cancer recurrence
- Partnerships & dealsHome | Digital Health, 15 Jul 2025Healx and SCI Ventures partner to help treat paralysis using AI
- Fundingcambridgeindependent.co.uk, 2 Jul 2025Healx secures $2m from SCI Ventures for neurotrauma focus
- Partnerships & dealsGenetic Engineering and Biotechnology News, 1 Jul 2025Healx and SCI Ventures Partner to Uncover Cures for Paralysis with AI-Driven Drug Discovery
- Partnerships & dealsBusiness Weekly, 30 Jun 2025$40m 'Superman' backed fund partners with Healx to fight paralysis
- Othercambridgeindependent.co.uk, 12 May 2025Healx welcomes NF specialist Dr Christopher Moertel to key role
